Table 3 Statistical information on patient and control groups prior and after matching for age and gender
Cohort characteristics | Unadjusted | Matched cases | ||||
|---|---|---|---|---|---|---|
Patients | Controls | p-value | Patients | Controls | p-value | |
Subjects (N) | 83 | 259 | N/A | 83 | 77 | N/A |
Mean age (yr.) range | 49.45 20–73 | 41.79 20–86 | < 0.001* | 49.45 20–73 | 48.05 22–86 | 0.551* |
Gender (N, %) | ||||||
Male | 43 (51.8%) | 73 (28.2%) | < 0.001† | 43 (51.8%) | 29 (37.7%) | 0.072† |
Female | 40 (48.2%) | 186 (71.8%) | 40 (48.2%) | 48 (62.3%) | ||
CMV IgG (N, %) | ||||||
Yes | 75 (90.4%) | 214 (82.6%) | 0.09† | 75 (90.4%) | 76 (98.7%) | 0.035† |
No | 8 (9.6%) | 45 (17.4%) | 8 (9.6%) | 1 (1.3%) | ||